# FDA Inspection 1041173 - Biomat USA Inc - February 02, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/db81fa80-2a9e-4602-bf54-4052e2b47161
Source feed: FDA_Inspections

> FDA Inspection 1041173 for Biomat USA Inc on February 02, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1041173
- Company Name: Biomat USA Inc
- Inspection Date: 2018-02-02
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1114622 - 2019-12-20](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/a39a7430-197c-4450-a4db-b82d927452d7)
- [FDA Inspection 913423 - 2015-02-11](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/eef1fc32-b099-4b1a-9a4b-31a6d452f981)
- [FDA Inspection 816496 - 2013-01-31](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/d2c1d5c1-19fb-4f0c-84c2-1347515a3439)
- [FDA Inspection 706463 - 2011-01-20](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/dfe6d39e-b849-465c-b30b-783f57179c00)
- [FDA Inspection 694728 - 2010-10-20](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/a00532dc-c23b-42d1-9de1-ba3089b03446)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/81f33cad-5f73-4670-802a-d45be89af964

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d